Total Reports
15
FDA CVM filings
Dog /
FDA CVM · 2025 release 15 reports on file
Pointing Dog - Hungarian Wire-haired (Vizsla) - FDA Adverse Event Profile
Adverse-event records for Pointing Dog - Hungarian Wire-haired (Vizsla) (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among dog breeds, Pointing Dog - Hungarian Wire-haired (Vizsla) is #397 by FDA report volume; 0.0% of its 15 reports (0) were death-coded.
- #397
- most-reported dog breed
- 0.0%
- death-coded report share
- 4
- Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
- 6.0 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
0
of 15 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
6.0 yr
25.8 kg avg weight
Death-Coded Outcome Share
Pointing Dog - Hungarian Wire-haired (Vizsla) death-coded reports 0.0%
Cross-breed median
0.0% of 15 pointing dog - hungarian wire-haired (vizsla) reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 25.8 kg (56.9 lbs)
Top Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 4
Vomiting 4
Other abnormal test result NOS 2
Lack of efficacy (ectoparasite) - flea 2
Emesis 1
Most Referenced Drugs
Milbemycin Oxime + Spinosad 4
Trilostane 3
Milbemycin Oxime + Praziquantel 2
Lotilaner 2
Spinosad 1
Outcome Breakdown
Outcome Unknown
7 (46.7%)
Recovered/Normal
6 (40.0%)
Ongoing
2 (13.3%)
Gender Distribution
Male 8 (53.3%)
Female 7 (46.7%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2013 | 1 | |
| 2014 | 1 | |
| 2015 | 2 | |
| 2016 | 1 | |
| 2017 | 4 | |
| 2020 | 2 | |
| 2021 | 2 | |
| 2022 | 2 | |
Pointing Dog - Hungarian Wire-haired (Vizsla) Pet Health Insights
Pointing Dog - Hungarian Wire-haired (Vizsla) accounts for 15 FDA adverse event reports, ranking #397 by volume among dog breeds, with 0 reports (0.0%) coded as a death outcome. Mean age at report: 6.0 years, average weight 25.8 kg (56.9 lbs).
Top reported signs: Lethargy (see also Central nervous system depression in 'Neurological') (4), Vomiting (4), Other abnormal test result NOS (2). Most-referenced drug: Milbemycin Oxime + Spinosad (4 reports), followed by Trilostane (3) and Milbemycin Oxime + Praziquantel (2).
Outcome coding on 15 status-recorded reports is dominated by Outcome Unknown (46.7%). Annual submissions ranged 2,013-2,022 across 8 years on file.
Dog Breeds With a Similar Report Volume
Bulldog (unspecified)
16 reports · 18.8% death rate
Hound - Swiss - (Lucerne Hound (Luzerner Laufhund), Schwyz Hound (Schweizer Laufhund), Bernese Hound, Jura Hound)
14 reports · 0.0% death rate
Kai Ken
16 reports · 6.3% death rate
Karelian Bear Dog
14 reports · 7.1% death rate
Pointing Dog - French (unspecified)
16 reports · 0.0% death rate
Barbet
17 reports · 0.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Pointing Dog - Hungarian Wire-haired (Vizsla)? ▼
There are 15 adverse event reports involving Pointing Dog - Hungarian Wire-haired (Vizsla) in the FDA database, with 0 reports involving death (0.0% death rate). Pointing Dog - Hungarian Wire-haired (Vizsla) ranks #397 by report volume.
What are the most common adverse reactions reported for Pointing Dog - Hungarian Wire-haired (Vizsla)? ▼
The most commonly reported adverse reactions for Pointing Dog - Hungarian Wire-haired (Vizsla) are Lethargy (see also Central nervous system depression in 'Neurological') (4 reports), Vomiting (4 reports), Other abnormal test result NOS (2 reports), Lack of efficacy (ectoparasite) - flea (2 reports), Emesis (1 reports).
What drugs are most frequently associated with Pointing Dog - Hungarian Wire-haired (Vizsla) adverse events? ▼
The drugs most frequently referenced in Pointing Dog - Hungarian Wire-haired (Vizsla) adverse event reports are Milbemycin Oxime + Spinosad (4 reports), Trilostane (3 reports), Milbemycin Oxime + Praziquantel (2 reports), Lotilaner (2 reports), Spinosad (1 reports).
What is the average age of Pointing Dog - Hungarian Wire-haired (Vizsla) in adverse event reports? ▼
The average age of Pointing Dog - Hungarian Wire-haired (Vizsla) at the time of adverse event reports is 6.0 years, with an average weight of 25.8 kg (56.9 lbs).
Does a high number of adverse event reports mean Pointing Dog - Hungarian Wire-haired (Vizsla) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Pointing Dog - Hungarian Wire-haired (Vizsla) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.